Search

Population PK/PD analysis for efgartigimod Phase 3 study in myasthenia gravis patients.

Therapeutic area :

Marostica E., Ahsman M., Van Bragt T., Noukens J., T’joen C., Ulrichts P., Vis P., Rossenu S., Steeg van T. Population PK/PD analysis for efgartigimod Phase 3 study in myasthenia gravis patients. PAGE 2023 [Link to publication]

Our expertise

Anesthesiology Paediatrics Diabetes General modelling Gastrointestinal Diseases Endocrinology/Sexual health Blood disorders Oncology Cardiovascular Peripheral Nervous System Pain Anti-infectives and immunology CNS Lung Diseases Biologicals Safety pharmacology Methods